Bamlanivimad to help prevent the progression of COVID disease in high risk patients

The FDA has approved the use of this medication (COVID-19 antibody) for treatment of high-risk patients to help prevent the progression of Covid disease. This is a great day during this pandemic, because there’s finally some options to help keep people from getting too sick to be admitted to the hospital. So far the US has purchased 300,000 doses, so don't expect this to be readily available for use. But soon enough!

Category